Review: taking Cetirizine hydrochloride allergy and Sodium monofluorophosphate together


Summary

Drug interactions are reported among people who take Cetirizine hydrochloride allergy and Sodium monofluorophosphate together. This review analyzes the effectiveness and drug interactions between Cetirizine hydrochloride allergy and Sodium monofluorophosphate. It is created by eHealthMe based on reports of 6 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Cetirizine hydrochloride allergy and Sodium monofluorophosphate >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Cetirizine Hydrochloride Allergy

Cetirizine hydrochloride allergy has active ingredients of cetirizine hydrochloride. It is often used in allergies. (latest outcomes from Cetirizine hydrochloride allergy 447 users)

Sodium Monofluorophosphate

Sodium monofluorophosphate has active ingredients of fluoride. It is often used in osteoporosis. (latest outcomes from Sodium monofluorophosphate 8 users)

On Aug, 30, 2016

6 people who take Cetirizine Hydrochloride Allergy, Sodium Monofluorophosphate are studied.


Number of reports submitted per year:

Cetirizine hydrochloride allergy and Sodium monofluorophosphate drug interactions.

Drug effectiveness over time:

Cetirizine Hydrochloride Allergy:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Sodium Monofluorophosphate:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Cetirizine Hydrochloride Allergy:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 0 people)
Sodium Monofluorophosphate:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Cetirizine Hydrochloride Allergy:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Sodium Monofluorophosphate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • urticaria
2 - 5 years:
  • drowsiness
  • dry mouth
  • headache
  • heartburn - chronic
  • increased tendency to bruise
  • insomnia
  • itching
  • malaise
  • menstruation irregular
  • miosis
5 - 10 years:
  • drowsiness
  • dry mouth
  • headache
  • heartburn - chronic
  • increased tendency to bruise
  • insomnia
  • itching
  • malaise
  • menstruation irregular
  • miosis
not specified:
  • back pain
  • chest pain
  • culture urine positive
  • depression
  • diarrhoea
  • flushing
  • headache
  • pyrexia
  • sleep apnoea syndrome
  • tachypnoea

Most common drug interactions by gender *:

female:
  • headache
  • back pain
  • chest pain
  • culture urine positive
  • diarrhoea
  • drowsiness
  • dry mouth
  • flushing
  • heartburn - chronic
  • increased tendency to bruise

Most common drug interactions by age *:

30-39:
  • drowsiness
  • dry mouth
  • headache
  • heartburn - chronic
  • increased tendency to bruise
  • insomnia
  • itching
  • malaise
  • menstruation irregular
  • miosis
40-49:
  • urticaria
50-59:
  • chest pain
  • culture urine positive
  • diarrhoea
  • pyrexia
  • tachypnoea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Cetirizine hydrochloride allergy and Sodium monofluorophosphate?

Can you answer these questions?

More questions for: Cetirizine hydrochloride allergy, Sodium monofluorophosphate

You may be interested in these reviews

More reviews for: Cetirizine hydrochloride allergy, Sodium monofluorophosphate

On eHealthMe, Cetirizine hydrochloride allergy (cetirizine hydrochloride) is often used to treat allergies. Sodium monofluorophosphate (fluoride) is often used to treat osteoporosis. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.